An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer

Chung Wei Fan, Hong Arh Fan, Soon Hwei Hsu, Chang Chuan Chan, Shih Yuan Chen, Yuan Hsun Hsu, Err Cheng Chan

研究成果: 雜誌貢獻文章同行評審

7 引文 斯高帕斯(Scopus)

摘要

The goal of this study was to develop a simple and rapid in vitro drug resistance assay to ascertain the effectiveness of 5-fluorouracil (5-FU) for the individual therapy of colorectal cancer. Colorectal cancer cells were isolated from tumor specimens and, after 4 h exposure to high doses of 5-FU cell viability was measured with an ATP assay. The average IC 50 concentration for 5-FU was calculated as 4000 μg/ml from 35 patients' tumors. The tumor cells were defined as extreme drug resistance with a survival rate 1 standard deviation (SD) over IC 50, low drug resistance (LDR) with a survival rate 1 SD below IC 50, and intermediate drug resistance (IDR) with survival rate between these two. The drug resistant assay for 102 patients' cancer cells showed that the proportion of patients with LDR to 5-fluorouracil was 19%. The in vitro drug resistance of the cancer cells was not correlated with cancer stages or by patient sex or age. However, most mucinous and poor differentiated cancer cells showed extreme or IDR. The in vitro ATP assay values for 25 Duke's D patients receiving postoperative 5-FU chemotherapy were comparable with clinical postchemotherapy responses. The sensitivity and specificity of the assay were 100 and 95%, respectively. This short time-high dose drug exposure assay may serve as an aid to improve 5-FU treatment for individual chemotherapy.
原文英語
頁(從 - 到)181-188
頁數8
期刊Cancer Letters
214
發行號2
DOIs
出版狀態已發佈 - 10月 28 2004

ASJC Scopus subject areas

  • 癌症研究
  • 分子生物學
  • 腫瘤科

指紋

深入研究「An in vitro short time-high dose drug exposure assay for predicting 5FU-resistance of colorectal cancer」主題。共同形成了獨特的指紋。

引用此